Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 69-25-0
2. Eledone Peptide
3. Eld 950
4. Eld-950
5. Eledoisin [inn]
6. Chembl373569
7. Eledoisin (inn)
8. Eledoisinum
9. Eledoisina
10. Eledoisine
11. 5-oxo-l-prolyl-l-prolyl-l-seryl-l-lysyl-l-alpha-aspartyl-l-alanyl-l-phenylalanyl-l-isoleucylglycyl-l-leucyl-l-methioninamide
12. Eledoisine [inn-french]
13. Eledoisina [inn-spanish]
14. Fi 6225 Tf/ocoa
15. Unii-oky3285j18
16. Brn 4796573
17. Dsstox_cid_26926
18. Dsstox_rid_82022
19. Dsstox_gsid_46926
20. Schembl158143
21. Gtpl2086
22. Dtxsid1046926
23. Chebi:135903
24. Oky3285j18
25. Tox21_112815
26. Bdbm50194558
27. Akos024456851
28. Cas-69-25-0
29. Ncgc00167276-01
30. Ntoc00000202-01
31. 5-oxo-l-prolyl-l-prolyl-l-seryl-l-lysyl-l-aspartyl-l-alanyl-l-phenylalanyl-l-isoleucylglycyl-l-leucyl-l-methioninamide
32. C20029
33. D07936
34. 069e250
35. 076e373
36. Q5358600
| Molecular Weight | 1188.4 g/mol |
|---|---|
| Molecular Formula | C54H85N13O15S |
| XLogP3 | -3.6 |
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 36 |
| Exact Mass | 1187.60088023 g/mol |
| Monoisotopic Mass | 1187.60088023 g/mol |
| Topological Polar Surface Area | 463 Ų |
| Heavy Atom Count | 83 |
| Formal Charge | 0 |
| Complexity | 2270 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neurotransmitter Agents
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
33
PharmaCompass offers a list of Eledoisin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eledoisin manufacturer or Eledoisin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eledoisin manufacturer or Eledoisin supplier.
PharmaCompass also assists you with knowing the Eledoisin API Price utilized in the formulation of products. Eledoisin API Price is not always fixed or binding as the Eledoisin Price is obtained through a variety of data sources. The Eledoisin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Eledoisin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eledoisin, including repackagers and relabelers. The FDA regulates Eledoisin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eledoisin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Eledoisin supplier is an individual or a company that provides Eledoisin active pharmaceutical ingredient (API) or Eledoisin finished formulations upon request. The Eledoisin suppliers may include Eledoisin API manufacturers, exporters, distributors and traders.
Eledoisin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eledoisin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eledoisin GMP manufacturer or Eledoisin GMP API supplier for your needs.
A Eledoisin CoA (Certificate of Analysis) is a formal document that attests to Eledoisin's compliance with Eledoisin specifications and serves as a tool for batch-level quality control.
Eledoisin CoA mostly includes findings from lab analyses of a specific batch. For each Eledoisin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eledoisin may be tested according to a variety of international standards, such as European Pharmacopoeia (Eledoisin EP), Eledoisin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eledoisin USP).
